These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 8878022

  • 1. The expression of cytokeratins 7, 19, and 20 in primary and metastatic carcinomas of the liver.
    Maeda T, Kajiyama K, Adachi E, Takenaka K, Sugimachi K, Tsuneyoshi M.
    Mod Pathol; 1996 Sep; 9(9):901-9. PubMed ID: 8878022
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A subgroup of intrahepatic cholangiocarcinoma with an infiltrating replacement growth pattern and a resemblance to reactive proliferating bile ductules: 'bile ductular carcinoma'.
    Kozaka K, Sasaki M, Fujii T, Harada K, Zen Y, Sato Y, Sawada S, Minato H, Matsui O, Nakanuma Y.
    Histopathology; 2007 Sep; 51(3):390-400. PubMed ID: 17553067
    [Abstract] [Full Text] [Related]

  • 4. Diagnostic significance of aquaporin-1 in liver tumors.
    Mazal PR, Susani M, Wrba F, Haitel A.
    Hum Pathol; 2005 Nov; 36(11):1226-31. PubMed ID: 16260277
    [Abstract] [Full Text] [Related]

  • 5. Comparative immunohistochemical profile of hepatocellular carcinoma, cholangiocarcinoma, and metastatic adenocarcinoma.
    Lau SK, Prakash S, Geller SA, Alsabeh R.
    Hum Pathol; 2002 Dec; 33(12):1175-81. PubMed ID: 12514785
    [Abstract] [Full Text] [Related]

  • 6. High mobility group A1 is expressed in metastatic adenocarcinoma to the liver and intrahepatic cholangiocarcinoma, but not in hepatocellular carcinoma: its potential use in the diagnosis of liver neoplasms.
    Abe N, Watanabe T, Izumisato Y, Suzuki Y, Masaki T, Mori T, Sugiyama M, Fusco A, Atomi Y.
    J Gastroenterol; 2003 Dec; 38(12):1144-9. PubMed ID: 14714251
    [Abstract] [Full Text] [Related]

  • 7. Comparative immunohistochemical expression of p63 in human cholangiocarcinoma and hepatocellular carcinoma.
    Ramalho FS, Ramalho LN, Della Porta L, Zucoloto S.
    J Gastroenterol Hepatol; 2006 Aug; 21(8):1276-80. PubMed ID: 16872309
    [Abstract] [Full Text] [Related]

  • 8. Agrin immunohistochemistry facilitates the determination of primary versus metastatic origin of liver carcinomas.
    Somorácz A, Tátrai P, Horváth G, Kiss A, Kupcsulik P, Kovalszky I, Schaff Z.
    Hum Pathol; 2010 Sep; 41(9):1310-9. PubMed ID: 20471664
    [Abstract] [Full Text] [Related]

  • 9. Expression of cytokeratins 7 and 20 in primary carcinomas of the stomach and colorectum and their value in the differential diagnosis of metastatic carcinomas to the ovary.
    Park SY, Kim HS, Hong EK, Kim WH.
    Hum Pathol; 2002 Nov; 33(11):1078-85. PubMed ID: 12454811
    [Abstract] [Full Text] [Related]

  • 10. Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases.
    Chu P, Wu E, Weiss LM.
    Mod Pathol; 2000 Sep; 13(9):962-72. PubMed ID: 11007036
    [Abstract] [Full Text] [Related]

  • 11. Cytokeratin patterns of liver carcinomas induced by diethylnitrosamine in monkeys.
    Lapis K, Sarosi I, Bocsi J, Thorgeirsson UP.
    Lab Invest; 1995 Jun; 72(6):748-59. PubMed ID: 7540236
    [Abstract] [Full Text] [Related]

  • 12. Coordinate expression of cytokeratins 7 and 20 in prostate adenocarcinoma and bladder urothelial carcinoma.
    Bassily NH, Vallorosi CJ, Akdas G, Montie JE, Rubin MA.
    Am J Clin Pathol; 2000 Mar; 113(3):383-8. PubMed ID: 10705819
    [Abstract] [Full Text] [Related]

  • 13. The utility of keratin 903 as a new prognostic marker in mass-forming-type intrahepatic cholangiocarcinoma.
    Aishima S, Asayama Y, Taguchi K, Sugimachi K, Shirabe K, Shimada M, Sugimachi K, Tsuneyoshi M.
    Mod Pathol; 2002 Nov; 15(11):1181-90. PubMed ID: 12429797
    [Abstract] [Full Text] [Related]

  • 14. The alphavbeta6 integrin is a highly specific immunohistochemical marker for cholangiocarcinoma.
    Patsenker E, Wilkens L, Banz V, Osterreicher CH, Weimann R, Eisele S, Keogh A, Stroka D, Zimmermann A, Stickel F.
    J Hepatol; 2010 Mar; 52(3):362-9. PubMed ID: 20137822
    [Abstract] [Full Text] [Related]

  • 15. Distinction between hepatocellular carcinoma, cholangiocarcinoma, and metastatic carcinoma based on immunohistochemical staining for carcinoembryonic antigen and for cytokeratin 19 on paraffin sections.
    Balaton AJ, Nehama-Sibony M, Gotheil C, Callard P, Baviera EE.
    J Pathol; 1988 Dec; 156(4):305-10. PubMed ID: 2465399
    [Abstract] [Full Text] [Related]

  • 16. Cytoplasmic staining of TTF-1 in the differential diagnosis of hepatocellular carcinoma vs cholangiocarcinoma and metastatic carcinoma of the liver.
    Lei JY, Bourne PA, diSant'Agnese PA, Huang J.
    Am J Clin Pathol; 2006 Apr; 125(4):519-25. PubMed ID: 16627262
    [Abstract] [Full Text] [Related]

  • 17. Histologic differentiation of hepatocellular carcinoma from adenocarcinoma by a simple panel: evaluation of the pitfalls.
    Geramizadeh B, Boub R, Rahsaz M.
    Indian J Pathol Microbiol; 2007 Jul; 50(3):507-10. PubMed ID: 17883119
    [Abstract] [Full Text] [Related]

  • 18. Keratin polypeptides in malignant epithelial liver tumors. Differential diagnostic and histogenetic aspects.
    Fischer HP, Altmannsberger M, Weber K, Osborn M.
    Am J Pathol; 1987 Jun; 127(3):530-7. PubMed ID: 2438941
    [Abstract] [Full Text] [Related]

  • 19. Diagnostic utility of GLUT1 in the differential diagnosis of liver carcinomas.
    Roh MS, Jeong JS, Kim YH, Kim MC, Hong SH.
    Hepatogastroenterology; 2004 Jun; 51(59):1315-8. PubMed ID: 15362741
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.